Effect of anti-ulcer drugs on DNA synthesis in adult normal human hepatocytes in culture
Pierre Blanc
INSERM U-128, CNRS, Montpellier, Hôpital Saint-Eloi, Montpellier, France
Service d'Hépatogastroentérologie, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorJacques Liautard
INSERM U-128, CNRS, Montpellier, Hôpital Saint-Eloi, Montpellier, France
Service d'Hépatogastroentérologie, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorJölle Greuet
INSERM U-128, CNRS, Montpellier, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorJean Pierre Daures
Département d'Informatique Médicale, Hôpital Carrémeau, Nimes, France
Search for more papers by this authorJean-Michel Fabre
Service de Chirurgie C, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorDominique Larrey
Service d'Hépatogastroentérologie, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorHenri Michel
Service d'Hépatogastroentérologie, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorCorresponding Author
Patrick Maurel PhD
INSERM U-128, CNRS, Montpellier, Hôpital Saint-Eloi, Montpellier, France
INSERM U-128, CNRS BP5051, 1919 Route de Mende, 34033 Montpellier, France===Search for more papers by this authorPierre Blanc
INSERM U-128, CNRS, Montpellier, Hôpital Saint-Eloi, Montpellier, France
Service d'Hépatogastroentérologie, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorJacques Liautard
INSERM U-128, CNRS, Montpellier, Hôpital Saint-Eloi, Montpellier, France
Service d'Hépatogastroentérologie, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorJölle Greuet
INSERM U-128, CNRS, Montpellier, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorJean Pierre Daures
Département d'Informatique Médicale, Hôpital Carrémeau, Nimes, France
Search for more papers by this authorJean-Michel Fabre
Service de Chirurgie C, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorDominique Larrey
Service d'Hépatogastroentérologie, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorHenri Michel
Service d'Hépatogastroentérologie, Hôpital Saint-Eloi, Montpellier, France
Search for more papers by this authorCorresponding Author
Patrick Maurel PhD
INSERM U-128, CNRS, Montpellier, Hôpital Saint-Eloi, Montpellier, France
INSERM U-128, CNRS BP5051, 1919 Route de Mende, 34033 Montpellier, France===Search for more papers by this authorAbstract
The aim of this work was to investigate the effect of four H2 receptor antagonists, cimetidine, ranitidine, famotidine, nizatidine, and of two proton pump inhibitors, omeprazole and lansoprazole, on the mitotic response of human hepatocytes in primary culture. After plating at subconfluent density, cells were exposed to 0.2 to 20 μmol/L of these drugs for 48 hours, either in the absence or in the presence of epidermal growth factor (EGF). The rate of DNA synthesis was evaluated by [3H]-thymidine incorporation into genomic DNA. Both the basal rate of DNA synthesis and the extent of stimulation by EGF exhibited a wide interindividual variability, and were not correlated with the viability of freshly prepared cells. In contrast, the effects of anti-ulcer drugs on the rate of DNA synthesis were clearly reproducible from one culture to another. H2 receptor antagonists had no significant effect (P > .3) over the entire range of concentration tested, whereas omeprazole and lansoprazole significantly inhibited the rate of DNA synthesis by 60% to 90% at 20 μmol/L (P = .016). This effect was concentration dependent between 2 and 20 μmol/L. Neither of the drugs tested was cytotoxic under the conditions used in this work, as assessed by measurements of the de novo protein synthesis. We conclude that, in contrast to H2 receptor antagonists, omeprazole and lansoprazole are able to interfere with the replicative synthesis of DNA in human hepatocytes in culture, at suprapharmacological concentrations. Whether or not this effect is clinically significant remains to be established. (Hepatology 1995; 22:814–819.)
References
- 1
Fortner JG,
Maclean BJ,
Kim DK,
Howland WS,
Turnbull AD,
Goldiner P,
Carlen G, et al.
The seventies evolution in liver surgery for cancer.
Cancer
1981;
47:
2162–2166.
10.1002/1097-0142(19810501)47:9<2162::AID-CNCR2820470909>3.0.CO;2-5 CAS PubMed Web of Science® Google Scholar
- 2 Balasegaram M, Jorshy SK. Hepatic resection: the logical approach to surgical management of major trauma to the liver. Am J Surg 1981; 142: 580–583.
- 3 Hastings PR, Skillman JJ, Bushnell LS, Silen W. Antiacid titration in the presentation of acute gastrointestinal bleeding: a controlled randomized trial in 100 critically ill patients. N Engl J Med 1978; 298: 1041–1045.
- 4 Basso N, Bagarani M, Materia A, Fiorani S, Lunardi P, Speranza V. Cimetidine and antiacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients: controlled randomized trial. Am J Surg 1981; 141: 339–341.
- 5 Kanashima R, Agasur N, Furusawa M, Inokuchi K. Inhibitory effect of cimetidine on liver regeneration after two-thirds hepatectomy in rats. Am J Surg 1983; 146: 293–298.
- 6 Kanashima R, Nagasue N, Sakato K. Ranitidine as an inhibitor of liver regeneration. Am J Surg 1985; 149: 224–247.
- 7 Kanashima R, Kobayashi M. Famotidine does not inhibit liver regeneration. Eur Surg Res 1989; 21: 190–195.
- 8 Lee SD, Wang JY, Cho CH, Wu JC, Lu RH, Lai KH, Tsai YT, et al. Effects of H2-receptor antagonists on the rat liver after partial hepatectomy or carbon tetrachloride-induced hepatic injury. Scand J Gastroenterol 1986; 21: 984–990.
- 9 Kahn D, Svanas GW, Eagon PK, Makowka L, Podesta L, Chapchap P, Starzl TE, et al. Effect of an antiadrogenic H2-receptor antagonist on hepatic regeneration in rats. J Lab Clin Med 1988; 112: 232–239.
- 10 Hoffman JS, Berglund V, Steer CJ. Effects of H2-antagonists on rat liver regeneration. Gastroenterology 1992; 102: A822.
- 11 Koch KS, Leffert HL. Growth control of differential adult rat hepatocytes in primary culture. Ann N Y Acad Sci 1980; 349: 111–127.
- 12 Michalopoulos G, Jirtle RL, Kligerman AD, Cianciulli D, Novotny A. Liver regeneration studies in primary cultures of hepatocytes. Cancer Res 1982; 42: 4673–4682.
- 13 Nakamura T, Ichihara A. Control of growth and expression of differentiated functions of mature hepatocytes in primary culture. Cell Struct Funct 1985; 10: 1–16.
- 14 Francavilla A, Ove P, Polimeno L, Sciascia C, Coetzee ML, Pellici R, Todo S, et al. Different response to epidermal growth factor of hepatocytes in cultures isolated from male or female rat liver: inhibitory effect of estrogen on binding and mitogenic effect of epidermal growth factor. Gastroenterology 1987; 93: 597–605.
- 15 Tomomura A, Sawada N, Sattler GL, Kleinman HK, Pitot HC. The control of DNA synthesis in primary cultures of hepatocytes from adult and young rats: interactions of extracellular matrix components, epidermal growth factor, and the cell cycle. J Cell Physiol 1987; 130: 221–227.
- 16 Hirono S, Gohda E, Tsubaichi H, Tamada F, Nakayama H, Takahashi K, Sakiyama O, et al. Effect of histamine H2-receptors antagonists on DNA synthesis in adult rat hepatocytes in primary culture: cimetidine enhanced hepatocyte proliferation stimulated with insulin and epidermal growth factor. Pharmacol Res Commun 1987; 19. 479–499.
- 17 Francavilla A, Panella C, Polimeno L, Di Leo A, Makowka L, Barone M, Amoruso A, et al. Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro. J Hepatol 1989; 8: 32–41.
- 18 Strom SC, Jirtle RL, Jones RS, Novicki DL, Rosenberg MR, Novotny A, Irons G, et al. Isolation, culture and transplantation of human hepatocytes. J Natl Cancer Inst 1982; 68: 771–778.
- 19 Begue JM, Le Bigot JF, Guguen Guillouzo C, Kiechel JR, Guillouzo A. Cultured human hepatocytes: a new model for drug metabolism studies. Biochem Pharmacol 1983; 32: 1643–1646.
- 20 Blanc P, Etienne H, Daujat M, Fabre I, Zindy F, Domergue J, Astre C, et al. Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology 1992; 102: 1340–1350.
- 21 Strain AJ, Ismail T, Tsubouchi H, Arakaki N, Hishida T, Kitamura N, Daikuhara Y, et al. Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest 1991; 87: 1853–1857.
- 22 Blanc P, Etienne H, Daujat M, Fabre I, Domergue J, Astre C, Saint Aubert B, et al. Proliferative responsiveness of human hepatocytes in culture: evidence of the transitory expression of hepatotrophic factor(s) in the serum of patients with fulminant hepatitis or after partial hepatectomy. In: D Bernuau, G Feldman, eds. Liver Regeneration. Paris: J. Libbey Eurotext, 1992: 129–138.
- 23 Blanc P, Liautard J, Greuet J, Fabre JM, Larrey D, Michel H, Maurel P. Effects of H2-antagonist and omeprazole on DNA synthesis in human hepatocytes in primary culture. Gastroenterology 1993; 104: A878.
- 24 Armitage P. Statistical methods in medical research. London: Blackwell Scientific, 1977.
- 25 Curi-Pedrosa R, Daujat M, Pichard L, Ourlin JC, Clair P, Gervot L, Lesca P, et al. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. J Pharm Exp Ther 1994; 269: 384–392.
- 26 Somogyi A, Gugler R. Clinical pharmacokinetics of cimetidine. Clin Pharmacokinet 1983; 8: 463–495.
- 27 Grant SM, Langtry HD, Brogden RN. Ranitidine: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 1989; 37: 801–870.
- 28 Langtry HD, Grant SM, Goa KL. Famotidine: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 1989; 38: 551–590.
- 29 Price AH, Brogden RN. Nizatidine: a preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in peptic ulcer disease. Drugs 1988; 36: 521–539.
- 30 Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270–276.
- 31 Barradell L, Faulds D, McTavish D. Lansoprazole: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorder. Drugs 1992; 44: 225–250.
- 32 Diaz D, Fabre I, Daujat M, Saint-Aubert B, Bories P, Michel H, Maurel P. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 1990; 99: 737–747.
- 33 Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990; 4: 176–187.
- 34 Pichard L, Curi-Pedrosa R, Bonfils C, Jacqz-Aigrain E, Domergue J, Joyeux H, Cosme J, et al. Oxidative metabolism of lansoprazole by human liver cytochromes P450. Mol Pharmacol 1995; 47: 410–418.
- 35 Ghanayem BI, Karam WG, Golstein JA. Human CYP2C19 is a major omeprazole 5-hydroxylase as shown by comparison of activities of recombinant CYP2C enzymes expressed in yeast. [Abstract] ISSX Proc 1994; 6: 50.
- 36 Rost KL, Brösicke H, Brockmöller J, Scheffler M, Helge H, Roots I. Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Clin Pharmacol Ther 1992; 52: 170–180.
- 37 Jean Marie I, Dalet C, Blanchard JM, Astre C, Szawlowski A, Saint Aubert B, Joyeux H, et al. Inhibition of cytochrome P450p (P450IIIA1) gene expression during liver regeneration from two-thirds hepatectomy in the rat. Biochem Pharmacol 1988; 37: 3515–3521.
- 38 Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, et al. Cytokines down-regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993; 44: 707–715.